Vajavaara, H.; Mortensen, J.B.; Leivonen, S.-K.; Hansen, I.M.; Ludvigsen, M.; Holte, H.; Jørgensen, J.; Bjerre, M.; d’Amore, F.; Leppä, S.
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers 2021, 13, 398.
https://doi.org/10.3390/cancers13030398
AMA Style
Vajavaara H, Mortensen JB, Leivonen S-K, Hansen IM, Ludvigsen M, Holte H, Jørgensen J, Bjerre M, d’Amore F, Leppä S.
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers. 2021; 13(3):398.
https://doi.org/10.3390/cancers13030398
Chicago/Turabian Style
Vajavaara, Heli, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, Ida Monrad Hansen, Maja Ludvigsen, Harald Holte, Judit Jørgensen, Mette Bjerre, Francesco d’Amore, and Sirpa Leppä.
2021. "Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma" Cancers 13, no. 3: 398.
https://doi.org/10.3390/cancers13030398
APA Style
Vajavaara, H., Mortensen, J. B., Leivonen, S. -K., Hansen, I. M., Ludvigsen, M., Holte, H., Jørgensen, J., Bjerre, M., d’Amore, F., & Leppä, S.
(2021). Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers, 13(3), 398.
https://doi.org/10.3390/cancers13030398